SONATA: 50% Adverse Event Rate Reported for Lifitegrast

About half the patients with dry eyes who were treated with the experimental drug lifitegrast experienced treatment-emergent adverse events, although not severe ones, a new study has shown.
Medscape Medical News

Full Story →